Category:
Active Pharmaceutical Ingredients
CAS NO:
761423-87-4
Standard:
In-house Standards,
Diabetes 2
Ipragliflozin is a potent SGLT2 inhibitor developed for glycemic control. Its molecular formula is C19H20FNO4S (CAS: 986759-46-4). The core synthesis involves Suzuki coupling and chiral resolution to ensure high pharmaceutical purity.
Strictly contraindicated in severe renal impairment or dialysis patients. Storage requires sealed containers at -20°C under inert atmosphere to prevent hydrolysis. Handling mandates PPE due to potential sensitization risks.